Topic: How To Invest

Hello, just wondering what your thoughts are on Paladin Labs. Thanks.

Article Excerpt

Paladin Labs, $14, symbol PLB on Toronto (Shares outstanding: 14.9 million; Market cap: $209.0 million), is a Montreal-based specialty pharmaceutical company. Paladin sells its drugs to Canadian doctors who focus on urology, dermatology, pain management and women’s health. Paladin mainly buys, licences and markets drugs. It specializes in drugs with patents that are about to expire, and under-promoted drugs from large pharmaceutical companies, like Johnson & Johnson, Eli Lilly, Novartis and Pfizer. Paladin also buys new drugs, or those that are close to having their patents approved. It mainly gets these from small-to-medium sized pharmaceutical and biotechnology companies with no sales and marketing presence in Canada. Aside from handling other companies’ drugs, Paladin expects to launch several new drugs of its own over the next two years. Paladin promotes eight key brands. These include Twinject, a pre-filled, pen-sized auto-injector with two doses of epinephrine for the emergency treatment of allergic reactions, Metadol and Tridural (both of which treat chronic pain), Pennsaid (for arthritis),…